Himed
Supplier of calcium phosphate biomaterials (powders, granules, abrasives) and osseoconductive surface coatings (MATRIX® line) for dental and orthopedic medical device manufacturers; expanding into 3D-printable bioceramics via Lithoz partnership.
- CEO / Founder
- Dana Barnard
- Team Size
- 11-50
- Stage
- Active
- Latest Round
- Bootstrapped
Technology & Products
Key Products
Calcium phosphate powders (hydroxyapatite, TCP); Granules and abrasives; MATRIX® biocompatible surface coatings; Bioceramics Center of Excellence (3D printing rapid prototyping with Lithoz CeraFab S65); Type III anodization for titanium implants; Custom material characterization and R&D services; xFAB automated blasting system (launched June 2025)
Technological Advantage
VERIFIED: Lithoz partnership grants access to medical-grade bioceramic 3D printing (LithaBone product line using hydroxyapatite/TCP) on Lithoz CeraFab S65; co-developed new bioinks optimized for Lithoz printers; Bioceramics Center of Excellence (BCoE) launched 2024 at Himed HQ offers design support, SEM imaging, material analysis, and rapid prototyping. CLAIMED: xFAB automation enables precision, repeatability, and scalability for implant surface treatments; proprietary process for customized bioresorbable and osteoconductive materials.
Differentiation
Value Proposition
30+ years of proven calcium phosphate (hydroxyapatite/TCP) expertise; osseoconductive coatings improve implant integration and clinical outcomes; rapid prototyping and material customization via Bioceramics Center of Excellence; ISO 13485 certified and FDA registered for precision biomaterial supply.
How They Differentiate
Deep specialization in calcium phosphate materials for 30+ years (vs. generalist medical device companies); vertically integrated coating and texturing with proprietary xFAB automation; first-to-market Bioceramics Center of Excellence combining traditional biomaterials with Lithoz 3D printing; trusted supplier to leading global medical device OEMs across six continents.
Market & Competition
Target Customers
Medical device manufacturers, dental implant makers, orthopedic implant companies, research laboratories
Industry Verticals
Dental implants; Orthopedic implants; Spinal implants; Orthopedic fasteners; Medical research and laboratory
Competitors
Zimmer Biomet (integrated implant + coating supplier); Stryker Corporation (orthopedic and spine devices); Medtronic (dental and orthopedic implant materials); Inductos (calcium phosphate biomaterials)
Growth & Milestones
Growth Metrics
30+ years operational (founded 1991); ~40-52 employees; $5.8M estimated annual revenue (per RocketReach); supplying biomaterials to millions of dental and orthopedic implants globally; expansion into 3D-printable bioceramics (2023-2024).
Major Milestones
1991: Founded by Ed Garofalo and team; started as one-room operation at aerospace company; 1991-2020: 30-year track record in calcium phosphate biomaterial innovation; 2020: Dana Barnard joins as CEO (April 2020); 2023: Partnership with Lithoz for 3D-printable bioceramics research; 2023: R&D collaboration with Mercury Bio on organic osteogenic materials; 2024: Craig Rosenblum succeeds Ed Garofalo as President (January 2024); Ed Garofalo transitions to advisory role; 2024: Bioceramics Center of Excellence (BCoE) launched at Himed HQ; Lithoz CeraFab S65 Medical printer installation; June 2025: xFAB fully automated blasting system launched; May 2026: Partnership with Adva Cera announced for prototype-to-production bioceramic 3D printing
Notable Customers
Top-tier global medical device manufacturers (specific names not disclosed in public materials, but referenced as 'world's leading medical device manufacturers')